The combination of PTEN mRNA nanoparticles (mPTEN@NPs) successfully promoted the infiltration of CD8 + T and CD3 + T cells in a Pten-deficient mouse model of prostate cancer. This evidence concerns the gene PTEN and prostate carcinoma.